The father of Western medicine, Hippocrates (460 BC BC) is known to have used many plants and herbs for medicinal purposes. Hippocrates' use of

Size: px
Start display at page:

Download "The father of Western medicine, Hippocrates (460 BC BC) is known to have used many plants and herbs for medicinal purposes. Hippocrates' use of"

Transcription

1 UNIT 11 INVESTIGATE WESTERN HERBAL PRODUCTS

2 HISTORY OF TRADITIONAL WESTERN HERBAL MEDICINE The father of Western medicine, Hippocrates (460 BC BC) is known to have used many plants and herbs for medicinal purposes. Hippocrates' use of up to 400 plants are well documented in a collection called the Corpus Hippocraticum. Western herbal medicines have traditionally been used to help prevent and treat diseases. Many useful pharmaceuticals have been derived from such herbs, including: salicylic acid to make aspirin from the bark of the white willow tree (Salix alba); morphine from the poppy plant (Papaver somniferum); digitalin, digitoxin and digoxin from the plant foxglove (Digitalis purpurea); atropine from the belladonna plant (Atropa belladonna) and; quinine from the bark of the quinine tree (Cinchona ledgeriana)

3 Western herbal medicine (WHM) Western Herbal Medicine (WHM) is a clinical practice of healing using naturally occurring plant material or plants with little or no industrial processing. Medicines or extracts from crude plant material, such as root, bark, and flower, are used in multiple plant formulations to treat persons with disease and dysfunction and to promote health and well-being WHM is also referred to as traditional Western herbalism, herbal or botanical medicine, medical herbalism and phytotherapy. WHM is practised in Australia, Canada, New Zealand, the United Kingdom, the United States and Western Europe.

4 Traditional knowledge of WHM is evident in the use of individually tailored crude plant extracts in multiple plant formulations. Treatments directed at the cause of the problem, focusing holistically on the whole person with the intent to strengthen the overall constitution, shift causal and global patterns of dysfunction and imbalance Western herbal medicine involves using plants and plant material to create medicines to help prevent or treat various illnesses. These materials may use some or all parts of a plant, such as flowers, roots, fruits, leaves, and bark.

5 SAFETY, EFFICACY AND QUALITY ON HERBAL PRODUCTS WHO GUIDELINES Safety, effectiveness and quality tests to herbal medicines are limited due to their complex nature, authentication issues and lack of appropriate standardization. The safety, effectiveness and quality of finished herbal medicine products depend on the quality of their source materials, which can include hundreds of natural constituents, and how elements are processed while manufacturing them. Countries have their own set of laws and regulations for herbal medicines and traditional medicines. W H O recommends that each country or area should adopt a regulatory system to manage the appropriate use of herbal medicines. Adopting a regulatory mechanism has always helped in ensuring that herbal medicines have acceptable quality, safety and efficacy.

6 The WHO Guidelines for the assessment of herbal medicines may be consulted when assessment processes for herbal medicines are being prepared The W H O guidelines on good agricultural and collection practices for medicinal plants are intended for national regulatory bodies and offer advice on cultivation and collection methods, site selection, climate and soil considerations and the correct identification of seeds and plants These guidelines also offer guidance on post-harvest operations such as labelling and legal components including national and regional laws on quality standards, patent status and benefits sharing Protocols on safety, efficacy, standardization and documentation of herbal medicines have also been published by IUPAC subcommittee on biomolecular chemistry

7 European Regulations and Guidelines Herbal medicinal products fall within the scope of the European Directive 2001/83/EC that foresees marketing of each medicinal product and requires an ad-hoc authorisation to be granted on the basis of results of tests and experimentations concerning quality, safety and efficacy. The main features of Directive 2001/EC are traditional herbal medicine definition, simplified registration procedure, provisions for community herbal monographs and community list of herbal substances and preparations and establishment of the Committee for Herbal Medicinal Products (HMPC). Committee for Herbal Medicinal Products (HMPC), Committee of European Medicines Agency (EMA) is developing guidelines for quality, nonclinical studies, clinical efficacy and safety European Directive 2004/24/EC on traditional herbal medicinal products has brought forward specifically in recognition of the position that for many herbal medicines it was difficult for companies to meet the full requirements for a marketing authorisation, particularly in relation to efficacy, as are required under Directive 2001/83/EC

8 Committee for Herbal Medicinal Products (HMPC) HMPC is the agency responsible for the evaluation of medicinal products and to carry out tasks concerning the simplified registration and authorization of herbal medicinal products. HMPC establish Community herbal monographs and list herbal substances and preparations. Monographs in European Pharmacopoeia provide the quality requirements for herbal substances and preparations. HMPC has also addressed general quality matters in several guidance documents concerning to non-clinical, quality, clinical efficacy and safety issues. The HMPC is responsible for identifying the priority herbal substances/preparations/combinations to be covered by a monograph or a list entry.

9 Medicines and Healthcare products Regulatory Agency (MHRA) for UK Recognised globally as an authority in its field, the agency plays a leading role in protecting and improving public health and supports innovation through scientific research and development The agency has 3 centres: the Clinical Practice Research Datalink (CPRD), a data research service that aims to improve public health by using anonymised NHS clinical data the National Institute for Biological Standards and Control (NIBSC), a global leader in the standardisation and control of biological medicines the Medicines and Healthcare products Regulatory Agency (MHRA), the UK s regulator of medicines, medical devices and blood components for transfusion, responsible for ensuring their safety, quality and effectiveness Traditional herbal medicines registration scheme (THMRS) has been recently introduced by Medicines and Healthcare Products Regulatory Agency (MHRA, UK).

10 United States of America Regulations In United States, the term complementary/alternative medicines (CAM) are most commonly used for traditional medicine systems. "Complementary medicine" refers to use of CAM together with conventional medicine, such as using acupuncture, in addition to usual care to help lessen pain. Most use of CAM by Americans is complementary (National Center for Complementary and Alternative Medicine ( Alternative medicine refers to use of CAM in place of conventional medicine. "Integrative medicine" (also called integrated medicine) refers to a practice that combines both conventional and CAM treatments for which there is evidence of safety and effectiveness

11 FDA in its draft guidance Guidance for industry on complementary and alternative medicine products and regulation by the food and their regulation by the food and drug administration clarified different categories of Complimentary Alternative Medicines (CAM) products into cosmetic; device; dietary supplement; drug, as well as "new drug" and "new animal drug;" food; and food additive. FDA guidelines on botanical drug products established New Drug Application (NDA) route parallel closely the route followed for a synthetic new chemical entity

12 HERBS AS DIETARY SUPPLEMENTS IN USA The Dietary Supplement Health and Education Act (DSHEA) of 1994 classifies herbs as dietary supplements. This law defines supplements quite broadly as anything that supplements the diet. Supplements therefore include vitamins, minerals, herbs, amino acids, enzymes, organ tissues, metabolites, extracts, or concentrates. A major difference between a drug and a dietary supplement is that dietary supplements may not claim to diagnose, cure, mitigate, treat, or prevent illness It is interesting to note that dietary supplement manufacturers are allowed to make certain structure/function claims, which are often vaguely worded claims of health benefits. For example, an Echinacea product (often used to treat or prevent the common cold) might claim to support the body s natural defenses. Dietary supplements can be produced, sold, and marketed without first demonstrating safety and efficacy, as is required for pharmaceutical drugs.

13 EXAMPLES OF WESTERN HERBS St. John's Wort Black Cohosh Feverfew

14 EXAMPLES OF WESTERN HERBS evening primrose flower Boswellia White Willow Bark

15 Examples of Western Herbal Products Ingredients: Oregon Grape Root (Berberis aquafolium), Grain Alcohol, Deionized Water Serving Size: 333 mg/ml (30 drops) Dosage: General (long-term) drops, 2-3 times per day or as needed in juice or water. Properties: Bitter Tonic, Anti-bacterial Overview: Oregon Grape can be used acutely in larger doses or long term in smaller doses as a tonic. Complimentary Formulas: Liver-Detox Caution: Not recommended if pregnant References: Healthnotes Monographs, Healthnotes, Inc

16 Ingredients: Fresh St. John's Wort, Grain Alcohol, Deionized Water Amount Per Serving: 450 mg per 1 veggie capsule Serving Size: 1 capsule: 1-3 times daily Properties: Anti-Depressent, Sedative, Vulnerary (heals tissue) Indications: Clinical guidelines from the American College of Physicians-American Society of Internal Medicine suggest that St. John's wort can be considered an option along with conventional antidepressants for short-term treatment of mild depression (1). However, since St. John's wort has not been shown to be more effective and since St. John's wort causes many drug interactions, it might not be an appropriate choice for many patients, particularly those who take other conventional drugs. Adverse Effects: Orally, St. John's wort is usually well tolerated (2). Side effects can include insomnia, vivid dreams, restlessness, anxiety, agitation, irritability, gastrointestinal (GI) discomfort, diarrhea, fatigue, dry mouth, dizziness, and headache. Insomnia can often be alleviated by decreasing the dose or taking St. John's wort in the morning Caution: Not recommended if nursing or pregnatn. St. John's wort has been associated with potentially serious interactions with certain drugs. May potentiate MAO-inhibitors. Check with your doctor to see if St. John's Wort is appropriate if you are on medications or are severely depressed.

17 GROUP ACTIVITY!! FORM GROUP OF TWO MEMBERS (Total group would be 5) Choose one western herbs. Search information for western herbs with the intended used and effective dosage Search the information on evaluation method for quality, safety and efficacy of selected herbs.

Determining Whether A Dietary Supplement Study Requires an Investigational New Drug (IND)

Determining Whether A Dietary Supplement Study Requires an Investigational New Drug (IND) Determining Whether A Dietary Supplement Study Requires an Investigational New Drug (IND) 02/02/16 description Does a study that claims their dietary supplement promotes healthy joints and cartilage or

More information

HERBAL MEDICINES: Product Licence To Traditional Herbal Registration in the UK. Presented by: Mariam Aslam

HERBAL MEDICINES: Product Licence To Traditional Herbal Registration in the UK. Presented by: Mariam Aslam HERBAL MEDICINES: Product Licence To Traditional Herbal Registration in the UK Presented by: Mariam Aslam ESCOP European Scientific Cooperative On Phytotheapy (ESCOP) Founded in June 1989 as an umbrella

More information

Chapter 11. Major Characteristics of CAM. Research. CAM Healing Methods. Complementary and Alternative Medicine (CAM) CAM Healing Methods (continued)

Chapter 11. Major Characteristics of CAM. Research. CAM Healing Methods. Complementary and Alternative Medicine (CAM) CAM Healing Methods (continued) Chapter 11 Herbal and Alternative Therapies Complementary and Alternative Medicine (CAM) Considered outside mainstream health care Upper Saddle River, New Jersey 07458 All rights reserved. Major Characteristics

More information

European Medicines Agency COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL

European Medicines Agency COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL European Medicines Agency London, 12 November 2009 Doc. Ref. EMEA/HMPC/67644/2009 COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL GUIDELINE ON SELECTION OF TEST MATERIALS FOR GENOTOXICITY TESTING FOR

More information

European Food Safety Authority

European Food Safety Authority AF 01.10.2004 3a Discussion paper on Botanicals European Food Safety Authority SCIENTIFIC COMMITTEE Brussels, 25 June 2004 EFSA/SC/26 Final Discussion Paper on Botanicals and Botanical Preparations widely

More information

Safety Assessment of Botanicals and Botanical Preparations. Dr. Balasubramanian

Safety Assessment of Botanicals and Botanical Preparations. Dr. Balasubramanian Safety Assessment of Botanicals and Botanical Preparations Dr. Balasubramanian Introduction Plant materials and extracts (botanicals) form a major component in indigenous peoples traditional ingredients

More information

Particular challenges of evaluation of herbal combination products

Particular challenges of evaluation of herbal combination products Particular challenges of evaluation of herbal combination products Reinhard Länger, PhD, Assoc. Prof. Austrian Medicines and Medical Devices Agency (AGES MEA/BASG) Dept. for Herbal, Homeopathic & Veterinary

More information

The Safety and Effectiveness of Dietary Supplements

The Safety and Effectiveness of Dietary Supplements Assignment 4 The Safety and Effectiveness of Dietary Supplements In Depth: Supplements Supplements, according to the FDA, are a product containing ingredients like vitamins, minerals, herms, amino acids,

More information

Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan

Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan Outline Herbal Medicines in the U.S. Herbal Medicines in EU Herbal Medicines in Australia Herbal Medicines in Asia & Taiwan Regulatory Strategy

More information

Public Assessment Report Scientific discussion. Echinaforce Forte, tablet. Asp. No:

Public Assessment Report Scientific discussion. Echinaforce Forte, tablet. Asp. No: Public Assessment Report Scientific discussion Echinaforce Forte, tablet Echinacea purpurea (L.) Moench (purple coneflower) herba recens, dry extract (17-34:1) and Echinacea purpurea (L.) Moench (purple

More information

FDA Regulation of Claims on Dietary Supplement and Food Products

FDA Regulation of Claims on Dietary Supplement and Food Products FDA Regulation of Claims on Dietary Supplement and Food Products Patricia Kaeding August 2004 Topics FDA Overview What are claims Why claims matter Categories of claims Regulatory requirements for types

More information

Are You Considering Using CAM?

Are You Considering Using CAM? Are You Considering Using CAM? Decisions about your health care are important including decisions about whether to use complementary and alternative medicine (CAM). The National Center for Complementary

More information

Health Products Regulatory Authority IPAR. Public Assessment Report for a. Traditional Herbal Medicinal Product

Health Products Regulatory Authority IPAR. Public Assessment Report for a. Traditional Herbal Medicinal Product IPAR Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use Ginkgo-Biloba Pharma Nord film-coated tablets Ginkgo dry extract TR 1242/1/1 TR holder Pharma Nord ApS March 2018

More information

COPYRIGHTED MATERIAL. Introduction

COPYRIGHTED MATERIAL. Introduction 1 Introduction Pharmacology is the science of drugs and their effects on biological systems. A drug can be defined as a chemical that can cause a change in a biological system; the important biological

More information

U.S. FDA Perspective on Food Supplements/TM

U.S. FDA Perspective on Food Supplements/TM U.S. FDA Perspective on Food Supplements/TM IKHLAS A. KHAN National Center for Natural Products Research, Department of Pharmacognosy and Research Institute of Pharmaceutical Sciences, School of Pharmacy,

More information

Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use

Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use IPAR Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use Ginkgoforce Memory & Circulation Ginkgo Tablets Extract (as dry extract) from fresh leaves of Ginkgo biloba (Ginkgo

More information

The Regulation of Herbal Medicines in Europe

The Regulation of Herbal Medicines in Europe The Regulation of Herbal Medicines in Europe Chantel Henderson Avena Consultants Ltd, 6 Melville Terrace, Edinburgh, Scotland EH9 3BN Manuscript received : 16.05.2014 Manuscript accepted: 18.06.2014 The

More information

M I L L E R T H O M S O N LLP Barristers & Solicitors, Patent & Trade Mark Agents

M I L L E R T H O M S O N LLP Barristers & Solicitors, Patent & Trade Mark Agents M I L L E R T H O M S O N LLP Barristers & Solicitors, Patent & Trade Mark Agents Communiqué for Health Industry Clients on the Legal Retainer Program Canada s New Natural Health Products Regulations On

More information

COMPLETION OF THE CTD IN APPLICATION FOR A COMPLEMENTARY MEDICINE

COMPLETION OF THE CTD IN APPLICATION FOR A COMPLEMENTARY MEDICINE COMPLETION OF THE CTD IN APPLICATION FOR A COMPLEMENTARY MEDICINE MCC WORKSHOP 31 AUGUST 2015 DR NEIL GOWER MTECH HOM (UJ) CML (UNISA) MEMBER: MEDICINES CONTROL COUNCIL (MCC) CHAIRPERSON: COMPLEMENTARY

More information

REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011.

REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011. REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011. CHAPTER I Scope and definitions. Article 1 Scope.

More information

Overview Consumer Health Products Law and Compliance Issues

Overview Consumer Health Products Law and Compliance Issues Overview Consumer Health Products Law and Compliance Issues The First Asia Pacific Pharmaceutical Compliance Congress September 2011 CHONG JIN NG Assistant General Counsel Asia Shared Legal Services Consumer

More information

DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 31 March 2004

DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 31 March 2004 30.4.2004 Official Journal of the European Union L 136/85 DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 March 2004 amending, as regards traditional herbal medicinal products,

More information

Decision tree for the safety assessment of botanical cosmetic ingredients. Personal Care Products Council CIR Science and Support Committee

Decision tree for the safety assessment of botanical cosmetic ingredients. Personal Care Products Council CIR Science and Support Committee Decision tree for the safety assessment of botanical cosmetic ingredients Personal Care Products Council CIR Science and Support Committee Using the Decision Tree Provided as a guidance tool for finished

More information

Discussion by HMPC Drafting Group on Quality September Start of public consultation 15 February 2013

Discussion by HMPC Drafting Group on Quality September Start of public consultation 15 February 2013 1 2 3 15 January 2013 EMA/HMPC/13658/2013 Committee on Herbal Medicinal Products (HMPC) 4 5 6 7 Concept paper on use of recovered/recycled solvents in the manufacture of herbal preparations for use in

More information

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 01 September 2008 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4

More information

Introduction to Medicinal Plants & Quality Control

Introduction to Medicinal Plants & Quality Control Introduction to Medicinal Plants & Quality Control https://sites.google.com ١ Introduction ٢ Definition of medicinal plants: -The use of plants and plant extracts to treat illness and remain healthy in

More information

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) DRAFT COMMUNITY HERBAL MONOGRAPH ON EQUISETUM ARVENSE L., HERBA

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) DRAFT COMMUNITY HERBAL MONOGRAPH ON EQUISETUM ARVENSE L., HERBA European Medicines Agency Evaluation of Medicines for Human Use London, 31 October 2007 Doc. Ref. EMEA/HMPC/394894/2007 COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) DRAFT COMMUNITY HERBAL MONOGRAPH ON

More information

Discussion by HMPC Drafting Group on Quality February Start of public consultation 27 June 2012

Discussion by HMPC Drafting Group on Quality February Start of public consultation 27 June 2012 1 2 3 22 May 2012 EMA/HMPC/312890/2012 Committee on Herbal Medicinal Products (HMPC) 4 5 6 7 8 Concept paper on non-pharmacopoeial reference standards for herbal substances, herbal preparations and herbal

More information

Good pharmacopoeial practices: Chapter on monographs on herbal medicines

Good pharmacopoeial practices: Chapter on monographs on herbal medicines Annex 7 Good pharmacopoeial practices: Chapter on monographs on herbal medicines Background Following the fiftieth meeting of the WHO Expert Committee on Specifications for Pharmaceutical Preparations,

More information

Public Assessment Report Scientific discussion

Public Assessment Report Scientific discussion Public Assessment Report Scientific discussion Echinagard, oral drops, solution (Echinacea purpurea (L.) Moench, fresh herb, expressed juice (1.7-2.5:1)) Asp no: 2008-0658 This module reflects the scientific

More information

Anurag Agarwal Chief Operating Officer Natural Remedies Pvt Ltd. Bangalore

Anurag Agarwal Chief Operating Officer Natural Remedies Pvt Ltd. Bangalore I ndian Herbals Global opportunities Anurag Agarwal Chief Operating Officer Natural Remedies Pvt Ltd. Bangalore Time : Date : 28 th June, 2007 16.00 pm to 17.30 pm Venue: Hotel Marriot, Hyderabad WORLD

More information

Public Assessment Report Scientific discussion. Ginsana, oral solution. Asp.no.:

Public Assessment Report Scientific discussion. Ginsana, oral solution. Asp.no.: Läkemedelsverket 2014-04-15 Public Assessment Report Scientific discussion Ginsana, oral solution (Panax ginseng C.A. Meyer, radix, standardised dry extract G115 Pharmaton (0.9-3.9:1, 40% ethanol)) Asp.no.:

More information

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON AVENA SATIVA L., HERBA

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON AVENA SATIVA L., HERBA European Medicines Agency Evaluation of Medicines for Human Use London, 4 September 2008 Doc. Ref. EMEA/HMPC/202966/2007 COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON

More information

EMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS

EMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use 25 October 1999 EMEA/HMPWP/23/99 EMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS UPDATED DRAFT POINTS

More information

DIRECTIVE AMENDING FOR TRADITIONAL HERBAL MEDICINAL PRODUCTS DIRECTIVE 2001/83/EC

DIRECTIVE AMENDING FOR TRADITIONAL HERBAL MEDICINAL PRODUCTS DIRECTIVE 2001/83/EC PROF. GIUSEPPE NISTICO Director Institute of Pharmacology University of Rome, Tor Vergata DIRECTIVE AMENDING FOR TRADITIONAL HERBAL MEDICINAL PRODUCTS DIRECTIVE 2001/83/EC RAPPORTEUR: Giuseppe Nisticò

More information

Developments in regulations for complementary medicines (including traditional medicines and other natural health products)

Developments in regulations for complementary medicines (including traditional medicines and other natural health products) Developments in regulations for complementary medicines (including traditional medicines and other natural health products) A/Professor Jo Barnes BPharm (Hons) PhD RegPharmNZ MPSNZ FLS School of Pharmacy,

More information

The Shifting Federal Regulation of Cannabis Products

The Shifting Federal Regulation of Cannabis Products The Durham Bar 2019 CLE Program The Shifting Federal Regulation of Cannabis Products Erica M. Jackson, FDA Partner K&L Gates February 6, 2019 Copyright 2018 by K&L Gates LLP. All rights reserved. OVERVIEW

More information

Decoding the Confusing Language of Vitamins. Yuliya Klopouh, M.H., Pharm.D

Decoding the Confusing Language of Vitamins. Yuliya Klopouh, M.H., Pharm.D Decoding the Confusing Language of Vitamins Yuliya Klopouh, M.H., Pharm.D Nutritional Supplements ( Vitamins, etc) History of Dietary supplements 1990 Nutritional Labeling and Education Act Permitted use

More information

WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS

WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS SEPTEMBER 23, 2009 COUNCIL OF THE CONVENTION SECTION ON THE QUALITY OF FOOD INGREDIENTS AND DIETARY SUPPLEMENTS INTRODUCTION The 1994 Dietary Supplement

More information

An herb is any plant or part of a plant that has nutritional or medicinal uses. It might be a leaf, root, flower, seed, bark or a fruit.

An herb is any plant or part of a plant that has nutritional or medicinal uses. It might be a leaf, root, flower, seed, bark or a fruit. Categorizing Herbs The Basics An herb is any plant or part of a plant that has nutritional or medicinal uses. It might be a leaf, root, flower, seed, bark or a fruit. The medical definition of medicine:

More information

Getting Your Ingredient to Market: Understanding Your Regulatory Options Venable LLP

Getting Your Ingredient to Market: Understanding Your Regulatory Options Venable LLP Getting Your Ingredient to Market: Understanding Your Regulatory Options 2013 Venable LLP 1 Overview of the Governing Laws 1. The Federal Food, Drug, and Cosmetic Act ("FD&C Act"): Requires foods, cosmetics,

More information

Choosing the Right Herbs for You

Choosing the Right Herbs for You Choosing the Right Herbs for You A Presentation by Steve Blake, D.Sc. Doctor of Holistic Health Master Herbalist Registered Herbalist, AHG When Drugs can be the Right Choice Emergency Room Treatments Acute

More information

Dormeasan, oral drops, solution (Valeriana officinalis L., radix, tincture; Humulus lupulus L., strobulus, tincture)

Dormeasan, oral drops, solution (Valeriana officinalis L., radix, tincture; Humulus lupulus L., strobulus, tincture) Public Assessment Report Scientific discussion Dormeasan, oral drops, solution (Valeriana officinalis L., radix, tincture; Humulus lupulus L., strobulus, tincture) Asp. No: 2008-1029 This module reflects

More information

Client Alert. FDA Draft Guidance Broadens New Dietary Ingredient Definition and Extends Notification Requirements 1

Client Alert. FDA Draft Guidance Broadens New Dietary Ingredient Definition and Extends Notification Requirements 1 Contact Attorney Regarding This Matter: Emalee G. Murphy 202.677.4052 - direct 202.677.4053 - fax emalee.murphy@agg.com Attorneys at Law 171 17th Street NW Suite 2100 Atlanta, GA 30363-1031 404.873.8500

More information

QUALITY OF HERBAL MEDICINAL PRODUCTS: PRESENT REQUIREMENTS

QUALITY OF HERBAL MEDICINAL PRODUCTS: PRESENT REQUIREMENTS QUALITY OF HERBAL MEDICINAL PRODUCTS: PRESENT REQUIREMENTS Phytopharm 2015 Bonn, 21 24 July 2015 1 Dr. Barbara Steinhoff Bundesverband der Arzneimittel-Hersteller CONTENTS Production of herbal starting

More information

Food Legislation. Janet Worrell July 2014

Food Legislation. Janet Worrell July 2014 Food Legislation Janet Worrell July 2014 Topics to be covered Food legislation what is a supplement origin of food legislation Making a product from a concept claim development Regulation in transition

More information

The Marketing of a Food Ingredient Understanding a System that has Worked for 105 Years

The Marketing of a Food Ingredient Understanding a System that has Worked for 105 Years The Marketing of a Food Ingredient Understanding a System that has Worked for 105 Years Gary L. Yingling Food Policy Impact December 2011 Copyright 2011 by K&L Gates LLP. All rights reserved. Brief Historical

More information

Public Assessment Report Scientific discussion

Public Assessment Report Scientific discussion Public Assessment Report Scientific discussion Hypermin, tablet [Hypericum perforatum L., (St. John s wort) herba recens, dry extract (3.1-4.0:1) ethanol 60 %] Asp. no: 2008-1034 This module reflects the

More information

G O L D E N S E A L R O O T P O W D E R

G O L D E N S E A L R O O T P O W D E R T H E A M E R I C A N H E R B A L P R O D U C T S A S S O C I A T I O N S GUIDANCE CA PROPOSITION 65: G O L D E N S E A L R O O T P O W D E R AUGUST 2016 This document is the property of the American Herbal

More information

EFFECTIVE DATE: 05/02/2017

EFFECTIVE DATE: 05/02/2017 Background The purpose of this Guideline is to set forth the criteria that USP uses to determine whether or not a dietary ingredient qualifies for admission to the process for the development of a quality

More information

REGULATORY REQUIREMENTS FOR REGISTRATION OF HEALTH SUPPLEMENTS IN MALAYSIA

REGULATORY REQUIREMENTS FOR REGISTRATION OF HEALTH SUPPLEMENTS IN MALAYSIA REGULATORY REQUIREMENTS FOR REGISTRATION OF HEALTH SUPPLEMENTS IN MALAYSIA TAN JAS MIN National Pharmaceutical Regulatory Agency Ministry of Health Malaysia Email address: tanjasmin@npra.gov.my ORGANISATION

More information

FDLI ANNUAL CONFERENCE May 4, 2018

FDLI ANNUAL CONFERENCE May 4, 2018 FDLI ANNUAL CONFERENCE May 4, 2018 DIETARY SUPPLEMENTS RETAILER ISSUES AND LIABILITY Jean Frydman, Partner, Chair FDA Practice Fox Rothschild, LLP FDA Concern is Safety Only DHSEA Act of 1994 Know what

More information

Public Assessment Report Scientific discussion. Echinacea Friggs, effervescent tablet (Echinacea purpurea fresh herb, dried expressed juice (20-28:1))

Public Assessment Report Scientific discussion. Echinacea Friggs, effervescent tablet (Echinacea purpurea fresh herb, dried expressed juice (20-28:1)) Public Assessment Report Scientific discussion Echinacea Friggs, effervescent tablet (Echinacea purpurea fresh herb, dried expressed juice (20-28:1)) Asp. no: 2008-0557 This module reflects the scientific

More information

Public Assessment Report Scientific discussion. Ginsana, soft capsule. Asp.no.:

Public Assessment Report Scientific discussion. Ginsana, soft capsule. Asp.no.: Läkemedelsverket 2014-04-15 Public Assessment Report Scientific discussion Ginsana, soft capsule (Panax ginseng C.A. Meyer, radix, standardised dry extract G115 Pharmaton (0.9-3.9:1, 40% ethanol)) Asp.no.:

More information

Guideline on quality of herbal medicinal products 1 /traditional herbal medicinal products

Guideline on quality of herbal medicinal products 1 /traditional herbal medicinal products 31 March 2011 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) Committee on Herbal Medicinal Products (HMPC) Guideline on quality of herbal

More information

PLAN TO REGULATE THE COMPLEMENTARY MEDICINES INDUSTRY IN SOUTH AFRICA

PLAN TO REGULATE THE COMPLEMENTARY MEDICINES INDUSTRY IN SOUTH AFRICA PLAN TO REGULATE THE COMPLEMENTARY MEDICINES INDUSTRY IN SOUTH AFRICA René Doms FPS Healthcare Regulatory Consultant Dip Pharm Adv Dip (B&A) BIuris LLB South African Registered Pharmacist Fellow of the

More information

Potential Grounds for Revocation of a Traditional Herbal Registration

Potential Grounds for Revocation of a Traditional Herbal Registration Potential Grounds for Revocation of a Traditional Herbal Registration By Dr Rosanna Cooper In this article we will be exploring the potential grounds for revocation of the Traditional Herbal Registration

More information

A COMPREHENSION STUDY ON REGULATION OF HERBAL DRUGS IN USA, EUROPEAN UNION AND INDIA

A COMPREHENSION STUDY ON REGULATION OF HERBAL DRUGS IN USA, EUROPEAN UNION AND INDIA A COMPREHENSION STUDY ON REGULATION OF HERBAL DRUGS IN USA, EUROPEAN UNION AND INDIA Available online at www.ijdra.com REVIEW ARTICLE 1 Budhwar Vikaas *, 1 Yadav Sunita, 2 Choudhary Manjusha, 3 Nitesh

More information

The precarious status of! herbal products in the EU

The precarious status of! herbal products in the EU The precarious status of! herbal products in the EU Presentation to the EP Interest Group on CAM 16th November 2010 by The Herbal Working Group of the CAM Stakeholder Group Presenter: Robert Verkerk PhD

More information

Obstacles in Assessment and Licensing of Medicinal Products from Asian Traditional Medicines in Europe PD Dr. Werner Knöss BfArM

Obstacles in Assessment and Licensing of Medicinal Products from Asian Traditional Medicines in Europe PD Dr. Werner Knöss BfArM Obstacles in Assessment and Licensing of Medicinal Products from Asian Traditional Medicines in Europe PD Dr. Werner Knöss BfArM Traditional Use of Plants Echinacea Matricaria Angelica Ipecacuanha Harpagophytum

More information

GP for Ayurveda Medicines in Europe Ing. Cornelis J.M. Peters

GP for Ayurveda Medicines in Europe Ing. Cornelis J.M. Peters FP7 Health Partnering event 30 May 2012, Brussels SME session GP for Ayurveda Medicines in Europe Ing. Cornelis J.M. Peters International Open University -TASTAM Project idea/ Company expertise GP for

More information

COMPENDIUM OF MONOGRAPHS NATURAL HEALTH PRODUCTS DIRECTORATE

COMPENDIUM OF MONOGRAPHS NATURAL HEALTH PRODUCTS DIRECTORATE COMPENDIUM OF MONOGRAPHS NATURAL HEALTH PRODUCTS DIRECTORATE June 13 2013 Version 3.0 i FOREWORD Guidance documents are meant to provide assistance to industry and health care practitioners on how to comply

More information

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 16 March 2006 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU

More information

GSCI 2202 FOOD FOR HEALTH. Eat to compete: Dietary Supplements

GSCI 2202 FOOD FOR HEALTH. Eat to compete: Dietary Supplements GSCI 2202 FOOD FOR HEALTH Eat to compete: Dietary Supplements Dietary supplements on the market are: NOT regulated Could contain illegal substances Could be costly Could be harmful Current laws on dietary

More information

2. Selection criteria for substances of herbal origin relevant for standardization and quality control of herbal medicines 77

2. Selection criteria for substances of herbal origin relevant for standardization and quality control of herbal medicines 77 Annex 1 WHO guidelines for selecting marker substances of herbal origin for quality control of herbal medicines 1. Introduction 72 1.1 Background 72 1.1.1 Preparation of the document 73 1.2 Objectives

More information

dietary supplements are not subject to the premarket safety evaluations required of other new food ingredients.

dietary supplements are not subject to the premarket safety evaluations required of other new food ingredients. Dietary Supplements: regulation and research Diane F. Birt Distinguished Professor Food Science and Human Nutrition, Iowa State University Objectives: Students will: Understand supplement definitions Be

More information

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH 11 MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH Background The rules in this section are designed to ensure that advertisements that include health claims (please see Section 13 for health claims

More information

NDI: LOOKING BACK & AHEAD

NDI: LOOKING BACK & AHEAD NDI: LOOKING BACK & AHEAD Chi Hee Kim D i r e c t o r, W o r l d w i d e R e g u l a t o r y, G o v e r n m e n t a n d I n d u s t r y A f f a i r s H e r b a l i f e I n t e r n a t i o n a l o f A m

More information

market safety evaluations required of other new food ingredients.

market safety evaluations required of other new food ingredients. Dietary Supplements: regulation and research Diane F. Birt Distinguished Professor Food Science and Human Nutrition, Iowa State University Students will: Objectives: Understand supplement definitions Be

More information

Herbal medicines and supplements for cancer patients

Herbal medicines and supplements for cancer patients Herbal medicines and supplements for cancer patients Questions and answers Information for patients Pharmacy page 2 of 8 This leaflet is for all patients having treatment for cancer who are taking or thinking

More information

Ornsurang Teerawat

Ornsurang Teerawat ASEAN TRADITIONAL MEDICINES AND HEALTH SUPPLEMENTS REGULATORY AND HARMONIZATION UPDATE Ornsurang Teerawat 21.10.2014 \ http://trainstudenytp.wordpress.com ACCSQ (ASEAN Consultative Committee for Standard

More information

Taylor C. Wallace, PhD, CFS, FACN, March 22, 2018

Taylor C. Wallace, PhD, CFS, FACN, March 22, 2018 Food Ingredients Taylor C. Wallace, PhD, CFS, FACN, March 22, 2018 Disclosures Think Healthy Group, Inc. George Mason University, Department of Nutrition and Food Studies Journal of the American College

More information

Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use

Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use IPAR Public Assessment Report for a Traditional Herbal Medicinal Product for Human Use Agnus castus oral drops Tincture of Agnus castus fruit TR2309/017/001 A. Vogel Ireland Limited 28 November 2018 CRN008R68

More information

Gyan Rai, PhD 06/04/2015

Gyan Rai, PhD 06/04/2015 * Gyan Rai, PhD 06/04/2015 Objectives: 2 1. Current Definition of Probiotics 2. Regulatory Categorization & Intended Uses 3. Probiotics & Medical Foods- How to Fit? 4. Regulatory Implications & Considerations

More information

Herbal summaries for the public

Herbal summaries for the public Herbal summaries for the public Involvement of PCOs in preparation of herbal summaries Federica Castellani Medical Information Sector, European Medicines Agency An agency of the European Union Overview

More information

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) DRAFT COMMUNITY HERBAL MONOGRAPH ON VALERIANA OFFICINALIS L., RADIX AND HUMULUS LUPULUS L.

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) DRAFT COMMUNITY HERBAL MONOGRAPH ON VALERIANA OFFICINALIS L., RADIX AND HUMULUS LUPULUS L. European Medicines Agency Evaluation of Medicines for Human Use London, 14 May 2009 Doc. Ref.: EMEA/HMPC/585558/2007 COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) DRAFT COMMUNITY HERBAL MONOGRAPH ON VALERIANA

More information

Complementary and Alternative Medicine

Complementary and Alternative Medicine Complementary and Alternative Medicine Approaches to Health Care Complementary and alternative medicine (CAM) is a group of diverse medical and health care systems, practices, and products that are not

More information

Legal Requirements for the Control of Contaminants in Herbal Medicinal Products and Related Areas

Legal Requirements for the Control of Contaminants in Herbal Medicinal Products and Related Areas Legal Requirements for the Control of Contaminants in Herbal Medicinal Products and Related Areas AOAC International Workshop Erlangen, 11 October 2011 Dr. Barbara Steinhoff Contents Heavy metals Microorganisms

More information

Herbal medicinal products General comments with reference to the Matrix report

Herbal medicinal products General comments with reference to the Matrix report Herbal medicinal products General comments with reference to the Matrix report Herbert Schwabl DaKoMed Swiss Umbrella Organisa=on of Complementary Medicine www.dakomed.ch Plants as Medicines Herbal Medicine

More information

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL PROCEDURE FOR THE PREPARATION OF COMMUNITY MONOGRAPHS FOR TRADITIONAL HERBAL MEDICINAL PRODUCTS

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL PROCEDURE FOR THE PREPARATION OF COMMUNITY MONOGRAPHS FOR TRADITIONAL HERBAL MEDICINAL PRODUCTS European Medicines Agency Evaluation of Medicines for Human Use London, 11 January 2007 Ref: EMEA/HMPC/182320/2005 Rev. 2 COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL PROCEDURE FOR THE PREPARATION

More information

Session 2: Direct-to-Consumer Neurotechnology: Dietary Supplements Dietary Ingredients

Session 2: Direct-to-Consumer Neurotechnology: Dietary Supplements Dietary Ingredients 18 th Presidential Commission for the Study of Bioethical Issues August 20, 2014 Washington, DC Session 2: Direct-to-Consumer Neurotechnology: Dietary Supplements Dietary Ingredients Freddie Ann Hoffman,

More information

Ensuring the gap between science and practice is filled safely - MHRA

Ensuring the gap between science and practice is filled safely - MHRA Safeguarding public health Ensuring the gap between science and practice is filled safely - MHRA Diane Leakey Head of Information and Communications, MHRA April 2012 Agenda Who is MHRA? Why we have regulation?

More information

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON ECHINACEA PURPUREA (L.) MOENCH, HERBA RECENS

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON ECHINACEA PURPUREA (L.) MOENCH, HERBA RECENS European Medicines Agency Evaluation of Medicines for Human Use London, 8 May 2008 Doc. Ref. EMEA/HMPC/104945/2006Corr. 1 COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH

More information

Traditional Medicines Global Scenario

Traditional Medicines Global Scenario Traditional Medicines Global Scenario Muhammed A. Qayyum PTPMA Role of DRAP in Development of Traditional Medicine Industry in Pakistan Islamabad Feb 13, 2013 Absence of understanding does not warrant

More information

Laura Beatriz Herrero Montarelo, Maria Dolores Gómez Vázquez and Victorio José Teruel Muñoz

Laura Beatriz Herrero Montarelo, Maria Dolores Gómez Vázquez and Victorio José Teruel Muñoz Collaboration Laura Beatriz Herrero Montarelo, Maria Dolores Gómez Vázquez and Victorio José Teruel Muñoz Nutritional Risk Management Area of the Subdirectorate-General for Food Safety Promotion Spanish

More information

Healthy Living. with Arbonne

Healthy Living. with Arbonne Healthy Living with Arbonne Did You Know? The #1 killer of men and women in the U.S. is heart disease 2 out of 3 U.S. adults are overweight or obese U.S. adults consume approx. 2-3 lbs. of sugar each week!

More information

Commentary Pharmacopeial Forum 34(2) March-April 2008 Interim Revision Announcements to USP 30-NF 25 Revised June 30, 2008

Commentary Pharmacopeial Forum 34(2) March-April 2008 Interim Revision Announcements to USP 30-NF 25 Revised June 30, 2008 Commentary Pharmacopeial Forum 34(2) March-April 2008 Interim Revision Announcements to USP 30-NF 25 Revised June 30, 2008 Revision proposals published in Pharmacopeial Forum often elicit public comments

More information

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON ECHINACEA PALLIDA (NUTT.) NUTT., RADIX

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON ECHINACEA PALLIDA (NUTT.) NUTT., RADIX European Medicines Agency Evaluation of Medicines for Human Use London, 16 July 2009 Doc. Ref.: EMEA/HMPC/332350/2008 COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON ECHINACEA

More information

Public Assessment Report Scientific discussion. Cernitol Novum, film-coated tablet [Dry extract of crude pollen of Secale cereale L.

Public Assessment Report Scientific discussion. Cernitol Novum, film-coated tablet [Dry extract of crude pollen of Secale cereale L. Public Assessment Report Scientific discussion Cernitol Novum, film-coated tablet [Dry extract of crude pollen of Secale cereale L. (Rye), Phleum pratense L. (Timothy) and Zea mays L. (Maize) and Soft

More information

Harmonization effort for OTC monograph in Taiwan. Ms. Hsueh-Yung (Mary) Tai Deputy Director, Division of Medical Product, Taiwan FDA

Harmonization effort for OTC monograph in Taiwan. Ms. Hsueh-Yung (Mary) Tai Deputy Director, Division of Medical Product, Taiwan FDA Harmonization effort for OTC monograph in Taiwan Ms. Hsueh-Yung (Mary) Tai Deputy Director, Division of Medical Product, Taiwan FDA Outline Background OTC drug registration OTC monographs Future directions

More information

Developing Traditional Chinese Medicines as Botanical Drugs for the US Market

Developing Traditional Chinese Medicines as Botanical Drugs for the US Market Developing Traditional Chinese Medicines as Botanical Drugs for the US Market By Mukesh Kumar, PhD, RAC, and Hemant Jethwani, MS 30 August 2009 Therapeutic products derived from medicinal plants have been

More information

Dagmar Roth-Behrendt Vice-President of the European Parliament

Dagmar Roth-Behrendt Vice-President of the European Parliament 1 Dagmar Roth-Behrendt Vice-President of the European Parliament Herbal medicinal products: new Committee & European dimension Meeting on 23 September 2004 at the European Medicines Agency (EMEA) in London

More information

AUSTRALIAN REGULATORY DEVELOPMENTS IN COMPLEMENTARY MEDICINE

AUSTRALIAN REGULATORY DEVELOPMENTS IN COMPLEMENTARY MEDICINE AUSTRALIAN REGULATORY DEVELOPMENTS IN COMPLEMENTARY MEDICINE JON WARDLE OVERVIEW FREE TEXT PROBLEMS PROCESS THAT LED TO THERAPEUTIC GOODS (PERMISSABLE INDICATIONS) DETERMINATION NO.1 OF 2018 CONTROVERSIES

More information

Reyssouze, France Milan, Italy Palafolls, Spain

Reyssouze, France Milan, Italy Palafolls, Spain Healing by Nature Uncompromising solutions Drawing on decades of experience and with an uncompromising commitment to quality, Naturex is a global market leader in the supply of natural solutions, tailored

More information

Draft Guidance for Pharmacists on Extemporaneous Dispensing. Version 1

Draft Guidance for Pharmacists on Extemporaneous Dispensing. Version 1 1. Introduction Draft Guidance for Pharmacists on Extemporaneous Dispensing Version 1 The purpose of this guidance is to assist pharmacists in discharging their legal and professional obligations to patients

More information

Banned and Restricted Substances. David E. Olson, MD TPC 2017

Banned and Restricted Substances. David E. Olson, MD TPC 2017 Banned and Restricted Substances David E. Olson, MD TPC 2017 No disclosures to report Disclosures Famous Quote There is no room for second place. There is only one place in my game, and that s first place.

More information

European Medicines Agency Evaluation of Medicines for Human Use. Superseded COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL

European Medicines Agency Evaluation of Medicines for Human Use. Superseded COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL European Medicines Agency Evaluation of Medicines for Human Use COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL London, 3 July 2008 Doc. Ref. EMEA/HMPC/394894/2007 COMMUNITY HERBAL MONOGRAPH ON EQUISETUM

More information

Public Assessment Report Scientific discussion

Public Assessment Report Scientific discussion Public Assessment Report Scientific discussion Cynaramin, oral drops, solution (Peumus boldus Molina, folium, liquid extract, (1:10); Taraxacum officinale Web., radix and herba, liquid extract, (1:17))

More information

The Regulatory Environment in New Zealand. Michelle Palmer Natural Products New Zealand

The Regulatory Environment in New Zealand. Michelle Palmer Natural Products New Zealand The Regulatory Environment in New Zealand Michelle Palmer Natural Products New Zealand Nieuw Zeeland You are here New Zealand? It s where? Unique Product Offerings Botanical Origin Manuka honey Horopito

More information